Graduate Biochemistry Group, Department of Biochemistry and Molecular Biophysics, Kansas State University, 336 Ackert Hall, Manhattan, Kansas 66506, USA.
Molecular, Cellular and Developmental Biology Program, Division of Biology, Kansas State University, 338 Ackert Hall, Manhattan, Kansas 66506, USA.
Sci Rep. 2016 Jun 15;6:27873. doi: 10.1038/srep27873.
The proteasome degrades many short-lived proteins that are labeled with an ubiquitin chain. The identification of phosphorylation sites on the proteasome subunits suggests that degradation of these substrates can also be regulated at the proteasome. In yeast and humans, the unstructured C-terminal region of α7 contains an acidic patch with serine residues that are phosphorylated. Although these were identified more than a decade ago, the molecular implications of α7 phosphorylation have remained unknown. Here, we showed that yeast Ecm29, a protein involved in proteasome quality control, requires the phosphorylated tail of α7 for its association with proteasomes. This is the first example of proteasome phosphorylation dependent binding of a proteasome regulatory factor. Ecm29 is known to inhibit proteasomes and is often found enriched on mutant proteasomes. We showed that the ability of Ecm29 to bind to mutant proteasomes requires the α7 tail binding site, besides a previously characterized Rpt5 binding site. The need for these two binding sites, which are on different proteasome subcomplexes, explains the specificity of Ecm29 for proteasome holoenzymes. We propose that alterations in the relative position of these two sites in different conformations of the proteasome provides Ecm29 the ability to preferentially bind specific proteasome conformations.
蛋白酶体降解许多带有泛素链的短寿命蛋白质。蛋白酶体亚基上磷酸化位点的鉴定表明,这些底物的降解也可以在蛋白酶体水平上进行调节。在酵母和人类中,α7 的无结构 C 端区域含有一个带有丝氨酸残基的酸性斑,这些丝氨酸残基被磷酸化。尽管这些残基在十多年前就被鉴定出来了,但 α7 磷酸化的分子意义仍然未知。在这里,我们表明酵母 Ecm29(一种参与蛋白酶体质量控制的蛋白质)需要 α7 的磷酸化尾巴才能与蛋白酶体结合。这是第一个蛋白酶体磷酸化依赖于蛋白酶体调节因子结合的例子。Ecm29 已知可抑制蛋白酶体,并且经常在突变的蛋白酶体上富集。我们表明,Ecm29 结合突变蛋白酶体的能力除了先前表征的 Rpt5 结合位点外,还需要 α7 尾巴结合位点。这两个结合位点位于不同的蛋白酶体亚基上的需求,解释了 Ecm29 对蛋白酶体全酶的特异性。我们提出,在蛋白酶体不同构象中这两个位点的相对位置的改变为 Ecm29 提供了优先结合特定蛋白酶体构象的能力。